0001415889-23-011121.txt : 20230714 0001415889-23-011121.hdr.sgml : 20230714 20230714162619 ACCESSION NUMBER: 0001415889-23-011121 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230712 FILED AS OF DATE: 20230714 DATE AS OF CHANGE: 20230714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlong Tammy CENTRAL INDEX KEY: 0001984204 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 231089401 MAIL ADDRESS: STREET 1: C/O ELEVATION ONCOLOGY, INC. STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 3 1 form3-07142023_080714.xml X0206 3 2023-07-12 0 0001783032 Elevation Oncology, Inc. ELEV 0001984204 Furlong Tammy C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 false true false false CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 3.09 2031-05-06 Common Stock 79327 D Stock Option (Right to Buy) 3.09 2031-06-02 Common Stock 79327 D Stock Option (Right to Buy) 3.31 2032-02-29 Common Stock 35000 D Stock Option (Right to Buy) 0.75 2033-01-05 Common Stock 52500 D Stock Option (Right to Buy) 0.98 2033-02-14 Common Stock 28800 D Restricted Stock Unit Common Stock 4800 D The stock option vested as to 25% of the total shares on April 26, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The stock option vested as to 25% of the total shares on March 1, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The stock option vested as to 25% of the total shares on January 6, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The stock option vests as to 25% of the total shares on February 15, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. 25% of the restricted stock units ("RSUs") will vest on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The RSUs do not expire; they either vest or are canceled prior to the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Exhibit 24 - Power of Attorney /s/ Robert Yang, Attorney-in-Fact 2023-07-14 EX-24 2 ex24-07142023_080714.htm ex24-07142023_080714.htm

POWER OF ATTORNEY

The undersigned individual (the “Reporting Person”) hereby constitutes and appoints each of Joseph Ferra and Robert Yang, signing singly, with full power of substitution, as the Reporting Person’s true and lawful attorney in fact to:

(1)

prepare and file on behalf of such Reporting Person any and all reports, notices, communications and other documents (including, but not limited to, reports on Schedule 13D, Schedule 13G, Form 13-F, Form 3, Form 4 and Form 5) that such Reporting Person may be required to file with the Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended (together with the implementing regulations thereto, the “Exchange Act”) (collectively, the “Reports”), with respect to the Reporting Person’s ownership of, or transactions in, the securities of Elevation Oncology, Inc. (the “Company”), (whether directly or indirectly owned) by such Reporting Person;

(2)

do and perform any and all acts for and on behalf of the Reporting Person which may be necessary or desirable to complete and execute any such Reports, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney in fact, may be of benefit to, in the best interest of, or legally required by, the Reporting Person, it being understood that the documents executed by such attorney in fact on behalf of the Reporting Person pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney in fact may approve in such attorney in fact’s discretion.

The Reporting Person hereby grants to such attorney in fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the Reporting Person might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney in fact, or such attorney in fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The Reporting Person acknowledges that the foregoing attorney in fact, in serving in such capacity at the request of the Reporting Person, is not assuming any of the Reporting Person’s responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney with respect to the Reporting Person shall remain in full force and effect until such Reporting Person is no longer required to file any Reports with respect to the Reporting Person’s ownership of, or transactions in, the securities of the Company, unless earlier revoked in a signed writing delivered to the foregoing attorney in fact.




IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of July, 2023.

/s/ Tammy Furlong

Tammy Furlong